Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Barrington

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
European Journal of Nuclear Medicine|July 10, 1999
Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidismS F Barrington, M J O'Doherty, A G Kettle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2010
Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphomaS F Barrington, J E MacKewn, P Schleyer, et al.
British Journal of Haematology|September 12, 2025
MTV-guided radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T-cell therapyAndrea Kuhnl, S Bouziana, S F Barrington, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2021
Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell LymphomaMje Greuter, J J Eertink, G Jongeneel, et al.
Blood|March 31, 2023
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphomaJ J Eertink, G J C Zwezerijnen, M W Heymans, et al.
Blood Advances|May 4, 2021
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patientsJ J Eertink, C N Burggraaff, M W Heymans, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
European Journal of Nuclear Medicine|July 10, 1999
Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidismS F Barrington, M J O'Doherty, A G Kettle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2010
Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphomaS F Barrington, J E MacKewn, P Schleyer, et al.
British Journal of Haematology|September 12, 2025
MTV-guided radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T-cell therapyAndrea Kuhnl, S Bouziana, S F Barrington, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2021
Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell LymphomaMje Greuter, J J Eertink, G Jongeneel, et al.
Blood|March 31, 2023
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphomaJ J Eertink, G J C Zwezerijnen, M W Heymans, et al.
Blood Advances|May 4, 2021
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patientsJ J Eertink, C N Burggraaff, M W Heymans, et al.
Pageof 5